Pricing Log in Create free account

Aptevo Therapeutics Inc. (APVO) vs Silo Pharma, Inc. (SILO)

Aptevo Therapeutics Inc. and Silo Pharma, Inc. are both Biotechnology companies. Aptevo Therapeutics Inc. is the larger, with a market value of $2.3M against $2.1M — 1.1× the size. Aptevo Therapeutics Inc. grew revenue faster over the last twelve months: 92.9% against 0.00%. Across the 14 metrics below, Silo Pharma, Inc. leads on 8 and Aptevo Therapeutics Inc. on 6.

Valuation

Metric APVO SILO Biotechnology median
P/E n/m n/m 10.60
P/S 0.11 20.28 9.40
P/B 0.25 0.30 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.18 0.86 0.66
EV/Sales (0.37) (52.27) 9.02
Earnings yield (4,659.10%) (401.69%) (32.88%)
Free cash flow yield (1,718.19%) (268.42%) (23.13%)

Profitability

Metric APVO SILO Biotechnology median
Gross margin 0.00% 11.81% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (446.89%) (91.23%) (51.96%)
Return on assets (186.29%) (70.96%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric APVO SILO Biotechnology median
Revenue growth (TTM) 92.94% 0.00% 6.76%
EPS growth (last fiscal year) 99.72% 57.98% 29.88%
Revenue growth, 5-year CAGR (26.64%) 12.17% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric APVO SILO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.08 5.36 4.97
Net debt to EBITDA 0.83 1.61 1.01

Dividend

Metric APVO SILO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric APVO SILO Biotechnology median
Market cap 2.30m 2.05m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack